TGA Approval

SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial (375984)

ARTG ID

375984

ARTG Name

SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial

Sponsor

AbbVie Pty Ltd

ARTG Date

October 5, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ABBVIE PTY LTD

https://medical-cdn.nocode.com/drug_tga/51adddacc24428a126b6c1024b93eaa8.pdf

https://medical-cdn.nocode.com/drug_tga/251db23c825ebf280e39fb3161d6b9c4.pdf

Ingredient Name

Risankizumab

Empowering clinical research with data-driven insights and AI-powered tools.

SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial (375984) - TGA 批准文号 | MedPath